We are live on ! Find out more
PRC

Pearl River Capital Portfolio holdings

AUM $630M
1-Year Est. Return 17.08%
This Fund
S&P 500
This Quarter Est. Return
+11.57%
1 Year Est. Return
+17.08%
3 Year Est. Return
+20.29%
5 Year Est. Return
+57.93%
10 Year Est. Return
–
AUM
$590M
AUM Growth
+$51.8M
Cap. Flow
+$16.7M
Cap. Flow %
2.83%
Top 10 Hldgs %
10.58%
Holding
599
New
158
Increased
165
Reduced
167
Closed
108

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$8.41M
2
XOM icon
ExxonMobil
XOM
+$8.17M
3
AAPL icon
Apple
AAPL
+$4.15M
4
TXN icon
Texas Instruments
TXN
+$4.09M
5
ADBE icon
Adobe
ADBE
+$3.93M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$7M
2
DIS icon
Walt Disney
DIS
+$6.98M
3
MSFT icon
Microsoft
MSFT
+$6.69M
4
RTX icon
RTX Corp
RTX
+$5.96M
5
MRK icon
Merck
MRK
+$5.73M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 15.61%
2 Technology 15.28%
3 Healthcare 14.63%
4 Industrials 12.62%
5 Financials 12.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WBS icon
426
Webster Financial
WBS
$12.8B
$273K 0.05%
+5,768
New +$289K
WMG icon
427
Warner Music
WMG
$13.6B
$273K 0.05%
+7,791
New +$227K
AEIS icon
428
Advanced Energy
AEIS
$13.2B
$264K 0.04%
+3,075
New +$258K
WPM icon
429
Wheaton Precious Metals
WPM
$55.8B
$264K 0.04%
6,747
-15,150
-69% -$548K
CORT icon
430
Corcept Therapeutics
CORT
$12B
$263K 0.04%
12,950
-2,308
-15% -$57.9K
CHDN icon
431
Churchill Downs
CHDN
$6.02B
$262K 0.04%
2,476
-774
-24% -$81.5K
PAAS icon
432
Pan American Silver
PAAS
$20.3B
$261K 0.04%
+16,003
New +$256K
AXS icon
433
AXIS Capital
AXS
$7.61B
$259K 0.04%
4,784
-2,630
-35% -$142K
FNV icon
434
Franco-Nevada
FNV
$43.7B
$259K 0.04%
+1,900
New +$251K
DOCN icon
435
DigitalOcean
DOCN
$14.6B
$257K 0.04%
+10,099
New +$316K
CBSH icon
436
Commerce Bancshares
CBSH
$8.58B
$257K 0.04%
4,368
-1,255
-22% -$73.1K
PINC
437
DELISTED
Premier
PINC
$256K 0.04%
7,327
-5,997
-45% -$200K
FOLD
438
DELISTED
Amicus Therapeutics
FOLD
$256K 0.04%
20,954
-5,180
-20% -$58.3K
DXCM icon
439
DexCom
DXCM
$31.2B
$254K 0.04%
+2,241
New +$246K
EVTC icon
440
Evertec
EVTC
$1.93B
$251K 0.04%
7,761
-1,001
-11% -$32.9K
NJR icon
441
New Jersey Resources
NJR
$5.59B
$248K 0.04%
+4,990
New +$228K
AGL icon
442
Agilon Health
AGL
$1.8B
$247K 0.04%
612
+199
+48% +$93.3K
GEF icon
443
Greif
GEF
$5.12B
$247K 0.04%
3,678
-778
-17% -$52.4K
PTON icon
444
Peloton Interactive
PTON
$2.82B
$246K 0.04%
+31,035
New +$298K
ITT icon
445
ITT
ITT
$18.2B
$246K 0.04%
+3,031
New +$235K
OKTA icon
446
Okta
OKTA
$25.6B
$246K 0.04%
3,595
-9,611
-73% -$549K
OC icon
447
Owens Corning
OC
$12.3B
$245K 0.04%
2,874
-4,073
-59% -$357K
MDC
448
DELISTED
M.D.C. Holdings, Inc.
MDC
$245K 0.04%
7,749
-1,896
-20% -$58.6K
GTM
449
ZoomInfo Technologies
GTM
$1.08B
$244K 0.04%
+8,120
New +$280K
TRUP icon
450
Trupanion
TRUP
$1.06B
$244K 0.04%
+5,132
New +$267K
16 17
18
19 20

Similar funds

SCM
Sahana Capital Management Greenwich, Connecticut $645M AUM 23.48% 1-Year Est. Return
IFAM
Institutional & Family Asset Management Fort Collins, Colorado $654M AUM 12.29% 1-Year Est. Return
GIM
Greylin Investment Management Orange, Virginia $598M AUM 18.59% 1-Year Est. Return
MCM
McKinley Capital Management Anchorage, Alaska $571M AUM 36.44% 1-Year Est. Return
AT
Arden Trust Wilmington, Delaware $716M AUM 17.63% 1-Year Est. Return
AC
Abbrea Capital Greenbrae, California $755M AUM 24.68% 1-Year Est. Return
PWS
Private Wealth Strategies New Albany, Ohio $498M AUM 17.23% 1-Year Est. Return
RVPG
Relative Value Partners Group $772M AUM 15.6% 1-Year Est. Return

Pearl River Capital's Q4 2022 Portfolio in Review

As of Q4 2022, Pearl River Capital held 599 positions worth $590M, up 9.6% from $538M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Pearl River Capital's Q4 2022 filing shows 158 new, 165 increased, 167 reduced and 108 closed positions. Its largest new stake was Bristol-Myers Squibb: 111,556 shares worth $8.03M. The largest sale was Pfizer, an estimated $7M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.

  • Pearl River Capital's largest Q4 2022 buy was Bristol-Myers Squibb: 111,556 shares worth $8.03M.
  • Pearl River Capital added most to Honeywell in Q4 2022, an estimated $3.3M increase.
  • Pearl River Capital's biggest Q4 2022 reduction was Qualcomm, cutting an estimated $5.05M.
  • Pearl River Capital fully exited Pfizer in Q4 2022, selling an estimated $7M.
  • Pearl River Capital's ten largest holdings make up 11% of its $590M portfolio in Q4 2022.
  • Pearl River Capital opened 158 new positions and closed 108 in Q4 2022.
  • Pearl River Capital's portfolio value rose 9.6% quarter-over-quarter to $590M.

Based on Pearl River Capital's 13F filing for Q4 2022, filed 13 Feb 2023.